Skip to content

Neutral Alembic Pharma; target of Rs 580: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 580 in its research report dated February 01, 2023.

Read More

​ Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 580 in its research report dated February 01, 2023. Motilal Oswal recommended Neutral rating on Alembic Pharma with a target price of Rs 580 in its research report dated February 01, 2023.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish